[
  {
    "ts": null,
    "headline": "RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.",
    "summary": "RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.",
    "url": "https://finnhub.io/api/news?id=5464058e413b879deb74ee4accf177d3d2a2459d616d2986361f54e58973c0a0",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738685606,
      "headline": "RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.",
      "id": 132566535,
      "image": "",
      "related": "PFE",
      "source": "DowJones",
      "summary": "RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.",
      "url": "https://finnhub.io/api/news?id=5464058e413b879deb74ee4accf177d3d2a2459d616d2986361f54e58973c0a0"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer, Inc. (PFE) Q4 2024 Earnings Call Transcript",
    "summary": "Pfizer, Inc. (NYSE:PFE) Q4 2024 Earnings Conference Call February 4, 2025 10:30 AM ETCompany ParticipantsFrancesca DeMartino - Senior Vice President, Chief...",
    "url": "https://finnhub.io/api/news?id=27d584cbedfd1d53f2f5410f9b306e37c7c31f864e90cc83dca72cfc4a1bec86",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738683784,
      "headline": "Pfizer, Inc. (PFE) Q4 2024 Earnings Call Transcript",
      "id": 132557215,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer, Inc. (NYSE:PFE) Q4 2024 Earnings Conference Call February 4, 2025 10:30 AM ETCompany ParticipantsFrancesca DeMartino - Senior Vice President, Chief...",
      "url": "https://finnhub.io/api/news?id=27d584cbedfd1d53f2f5410f9b306e37c7c31f864e90cc83dca72cfc4a1bec86"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Q4 Earnings: Solid Results, But Guidance And Patent Concerns Drive The Stock Down",
    "summary": "Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See why I rate PFE stock as a Hold.",
    "url": "https://finnhub.io/api/news?id=9a836450b0f2d63f6b96e0663b2e84bf419dbc0bedfe98189a07b769ec5d22fa",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738683020,
      "headline": "Pfizer Q4 Earnings: Solid Results, But Guidance And Patent Concerns Drive The Stock Down",
      "id": 132556667,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1491484031/image_1491484031.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See why I rate PFE stock as a Hold.",
      "url": "https://finnhub.io/api/news?id=9a836450b0f2d63f6b96e0663b2e84bf419dbc0bedfe98189a07b769ec5d22fa"
    }
  },
  {
    "ts": null,
    "headline": "RFK Jr. Clears Committee Vote, Is On Track to Become Health Secretary",
    "summary": "RFK Jr. Clears Committee Vote, Is On Track to Become Health Secretary",
    "url": "https://finnhub.io/api/news?id=0b43db151dc4f299d4b9e1f14e1f684b15986e70cab478a73c939e744c680e38",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738679640,
      "headline": "RFK Jr. Clears Committee Vote, Is On Track to Become Health Secretary",
      "id": 132566537,
      "image": "",
      "related": "PFE",
      "source": "DowJones",
      "summary": "RFK Jr. Clears Committee Vote, Is On Track to Become Health Secretary",
      "url": "https://finnhub.io/api/news?id=0b43db151dc4f299d4b9e1f14e1f684b15986e70cab478a73c939e744c680e38"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects to growth to accelerate.",
    "summary": "Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects to growth to accelerate.",
    "url": "https://finnhub.io/api/news?id=bf57a6d29d16df32af204f037ffdb13f149eec6a836861abb4fe65b509b87abd",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738671180,
      "headline": "Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects to growth to accelerate.",
      "id": 132546257,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects to growth to accelerate.",
      "url": "https://finnhub.io/api/news?id=bf57a6d29d16df32af204f037ffdb13f149eec6a836861abb4fe65b509b87abd"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable?",
    "summary": "Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable?",
    "url": "https://finnhub.io/api/news?id=fed9230588219b0bc20e650e72c5e80b7f36efc008c3152d81a9ecbb51fc3d51",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738664635,
      "headline": "Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable?",
      "id": 132546236,
      "image": "",
      "related": "PFE",
      "source": "DowJones",
      "summary": "Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable?",
      "url": "https://finnhub.io/api/news?id=fed9230588219b0bc20e650e72c5e80b7f36efc008c3152d81a9ecbb51fc3d51"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Shares Rise on Better-Than-Expected 4Q",
    "summary": "Pfizer Shares Rise on Better-Than-Expected 4Q",
    "url": "https://finnhub.io/api/news?id=5c07de1566d3c8cadef8dc1903c599e35a1bc2cac12373c67912fb61eb68520f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738662180,
      "headline": "Pfizer Shares Rise on Better-Than-Expected 4Q",
      "id": 132546259,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Shares Rise on Better-Than-Expected 4Q",
      "url": "https://finnhub.io/api/news?id=5c07de1566d3c8cadef8dc1903c599e35a1bc2cac12373c67912fb61eb68520f"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock Rises on Fourth-Quarter Earnings Beat and Reaffirmed Guidance",
    "summary": "Pfizer Stock Rises on Fourth-Quarter Earnings Beat and Reaffirmed Guidance",
    "url": "https://finnhub.io/api/news?id=9598b9a199222ca3843e7dd57639e8b6433e6e0f55f3413eeb69c697df1ac7aa",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738660320,
      "headline": "Pfizer Stock Rises on Fourth-Quarter Earnings Beat and Reaffirmed Guidance",
      "id": 132546260,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Stock Rises on Fourth-Quarter Earnings Beat and Reaffirmed Guidance",
      "url": "https://finnhub.io/api/news?id=9598b9a199222ca3843e7dd57639e8b6433e6e0f55f3413eeb69c697df1ac7aa"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer : Fourth Quarter 2024 Presentation",
    "summary": "Fourth Quarter 2024 Earnings Teleconference February 4, 2025 1 Introduction ...",
    "url": "https://finnhub.io/api/news?id=a6c3801858e52d6ec11337feb7de64625e7506a46a1b2a5b6b494310e238f26e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738657155,
      "headline": "Pfizer : Fourth Quarter 2024 Presentation",
      "id": 132542931,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Fourth Quarter 2024 Earnings Teleconference February 4, 2025 1 Introduction ...",
      "url": "https://finnhub.io/api/news?id=a6c3801858e52d6ec11337feb7de64625e7506a46a1b2a5b6b494310e238f26e"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: more than six-fold increase in quarterly EPS",
    "summary": "Pfizer has announced adjusted EPS of $0.63 for the last three months of 2024, compared with $0.10 a year earlier, on revenues up 22% to nearly 17.8 billion .The pharmaceutical giant confirms its...",
    "url": "https://finnhub.io/api/news?id=f00d94325ba450da2c9faeb275536a1c96c6931099a7891b232fff5b25ca6171",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738654586,
      "headline": "Pfizer: more than six-fold increase in quarterly EPS",
      "id": 132542600,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Pfizer has announced adjusted EPS of $0.63 for the last three months of 2024, compared with $0.10 a year earlier, on revenues up 22% to nearly 17.8 billion .The pharmaceutical giant confirms its...",
      "url": "https://finnhub.io/api/news?id=f00d94325ba450da2c9faeb275536a1c96c6931099a7891b232fff5b25ca6171"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer 4Q Revenue Beat Leads to Swing to Profit",
    "summary": "By Denny Jacob Pfizer swung to a fourth-quarter profit as revenue increased from a year earlier and came in better than some on Wall Street had predicted. The drugmaker logged net income of...",
    "url": "https://finnhub.io/api/news?id=5e1338603073e0d3a7e68ca99cac45e0a91588714a1c3ced00c3e110169a480d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738653914,
      "headline": "Pfizer 4Q Revenue Beat Leads to Swing to Profit",
      "id": 132542493,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "By Denny Jacob Pfizer swung to a fourth-quarter profit as revenue increased from a year earlier and came in better than some on Wall Street had predicted. The drugmaker logged net income of...",
      "url": "https://finnhub.io/api/news?id=5e1338603073e0d3a7e68ca99cac45e0a91588714a1c3ced00c3e110169a480d"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Q4 Earnings Snapshot",
    "summary": "NEW YORK — NEW YORK — Pfizer Inc. on Tuesday reported fourth-quarter profit of $410 million. The New York-based company said it had net income of 7 cents per share. Earnings, adjusted for...",
    "url": "https://finnhub.io/api/news?id=acc1972b84d32df2443ed8c0a4985c79b196b6d75b394fc63668043572ef9468",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738652828,
      "headline": "Pfizer: Q4 Earnings Snapshot",
      "id": 132542401,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "NEW YORK — NEW YORK — Pfizer Inc. on Tuesday reported fourth-quarter profit of $410 million. The New York-based company said it had net income of 7 cents per share. Earnings, adjusted for...",
      "url": "https://finnhub.io/api/news?id=acc1972b84d32df2443ed8c0a4985c79b196b6d75b394fc63668043572ef9468"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer beats profit estimates on heart disease drug, COVID vaccine sales",
    "summary": "U.S. drugmaker Pfizer beatWall Street estimates for fourth-quarter profit on Tuesday,helped by strong sales of its heart disease drug and asmaller-than-feared drop in COVID vaccine sales. ...",
    "url": "https://finnhub.io/api/news?id=635bbe71b97a62983f1897094e7af671d9eaf09943bdcb45de60e704449c69e3",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738652405,
      "headline": "Pfizer beats profit estimates on heart disease drug, COVID vaccine sales",
      "id": 132542372,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "U.S. drugmaker Pfizer beatWall Street estimates for fourth-quarter profit on Tuesday,helped by strong sales of its heart disease drug and asmaller-than-feared drop in COVID vaccine sales. ...",
      "url": "https://finnhub.io/api/news?id=635bbe71b97a62983f1897094e7af671d9eaf09943bdcb45de60e704449c69e3"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer beats fourth-quarter profit estimates on cost-cutting efforts",
    "summary": "U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by cost-cutting efforts and better-than-expected sales of its COVID vaccine. On an adjusted...",
    "url": "https://finnhub.io/api/news?id=07ce2231d76ee1b261426433182bb73198ff1a2c687374418abadaf192ef38d3",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738652007,
      "headline": "Pfizer beats fourth-quarter profit estimates on cost-cutting efforts",
      "id": 132542312,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by cost-cutting efforts and better-than-expected sales of its COVID vaccine. On an adjusted...",
      "url": "https://finnhub.io/api/news?id=07ce2231d76ee1b261426433182bb73198ff1a2c687374418abadaf192ef38d3"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance",
    "summary": "Full-Year 2024 Revenues of $63.6 Billion, Reflecting 7% Year-over-Year Operational GrowthExcluding Contributions from Paxlovid and Comirnaty, Revenues Grew 12% OperationallyFull-Year 2024...",
    "url": "https://finnhub.io/api/news?id=6a703d01151168b4929e4ff36eccce5c19048da66c812ad9f9803c3fa7f48881",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738651563,
      "headline": "Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance",
      "id": 132542219,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Full-Year 2024 Revenues of $63.6 Billion, Reflecting 7% Year-over-Year Operational GrowthExcluding Contributions from Paxlovid and Comirnaty, Revenues Grew 12% OperationallyFull-Year 2024...",
      "url": "https://finnhub.io/api/news?id=6a703d01151168b4929e4ff36eccce5c19048da66c812ad9f9803c3fa7f48881"
    }
  },
  {
    "ts": null,
    "headline": "Alphabet results lead busy day of earnings",
    "summary": "Alphabet results lead busy day of earnings",
    "url": "https://finnhub.io/api/news?id=e5dfd889369f51d42634e6a306820faabbe83decbd89331f4eace874326224f3",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738648510,
      "headline": "Alphabet results lead busy day of earnings",
      "id": 132543886,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Alphabet results lead busy day of earnings",
      "url": "https://finnhub.io/api/news?id=e5dfd889369f51d42634e6a306820faabbe83decbd89331f4eace874326224f3"
    }
  }
]